全球重建网片市场 - 市场规模（依细分市场划分）、占有率、监管、报销、手术量及预测（至 2036 年）

本报告对全球重建网片市场进行了考察和分析，提供了区域市场规模、关键趋势、创新产品和技术以及竞争格局等资讯。

市场模型的主要组成如下：

已上市的重建网片及不断变化的竞争格局

• 主要行业趋势探讨
• 重建网片市场各细分市场的年度收入及市场预测（2015-2036 年）
• 各细分市场的总手术量、数量、平均售价和市场价值的详细数据

全球、区域与国家层面各市场的探讨

• 依地区划分的定性市场资讯针对全球趋势的国别市场分析
• 重建网片市场的SWOT分析
• 重建网片市场竞争格局与趋势探讨

全面的视角，包括对医疗保健系统的概述，有助于深入了解市场。此外，市场参与细分提供了有关报销政策和监管环境的信息，从而可以更深入地了解市场动态。

• 各国医疗保健系统概述
• 报销政策
• 医疗科技监管环境

对象企业

• Allergan Aesthetics
• W. L. Gore & Associates Inc
• MTF Biologics
• Surgalign Holdings Inc
• Coloplast A/S
• Ethicon Inc
• Boston Scientific Corp
• CR Bard Inc
• Integra LifeSciences Holdings Corp
• pfm medical gmbh
• Baxter International Inc
• LifeNet Health Inc
• 其他

Reconstruction Meshes Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.

Reconstruction Meshes are surgically implantable woven sheets that are used to repair or support organs and other tissues. The meshes are made either from synthetic material and/or bioengineered from animal tissues. Reconstruction Meshes are generally available in multiple sizes, thicknesses, and pore sizes, however for this market model the meshes are segmented based on the materials used to make them.

The market for breast reconstruction is mainly driven by patients with breast cancer, as that is the most common type of cancer in women. Many breast cancer patients undergo single or double mastectomies, thus requiring breast reconstruction. This population is expected to grow as the global female population ages and the prevalence of mastectomies increases. Breast reconstruction improves the quality of life of patients, such that the number of reconstruction Interventions is expected to increase.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Reconstruction Meshes and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Reconstruction Meshes market revenue by segment and market outlooks from 2015-2036.
• Granular data on total Interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Reconstruction Meshes market.
• Competitive dynamics insights and trends provided Reconstruction Meshes market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Allergan Aesthetics, W. L. Gore & Associates Inc, MTF Biologics, Surgalign Holdings Inc, Coloplast A/S, Ethicon Inc, Boston Scientific Corp, CR Bard Inc, Integra LifeSciences Holdings Corp, pfm medical gmbh, Baxter International Inc, LifeNet Health Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Reconstruction Meshes market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Reconstruction Meshes.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Reconstruction Meshes market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Reconstruction Meshes market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.